Qanti® IHC

Research only | Breast | Amplifier Integrator | ER, HER2, KI67 & PR

Description of use

Qanti® IHC is an AI-powered digital pathology software designed to assist anatomic pathologists in the quantitative interpretation of IHC for biomarkers including ER, PR, HER2, and Ki-67. Trained on high-quality data, it automatically excludes non-tumor cells and artifacts. It analyzes whole-slide images in under 3 minutes and displays over 3 million cells instantly after region selection. With a pathologist-friendly interface, standardized report templates, and broad scanner compatibility, Qanti® IHC integrates seamlessly into daily workflows. By standardizing IHC interpretation, it reduces inter-observer variability and diagnostic delays, especially in borderline cases like HER2-ultralow. Currently, Qanti® IHC is approved as an in vitro diagnostic device and reimbursed in South Korea.

The application content is provided by the respective AI vendors.